Press Releases • Oct 15, 2018 06:03 GMT
Based on good progress in strategic focus areas, Chr. Hansen raises ambitions to 9-11% organic growth next year
Press Releases • Oct 15, 2018 06:02 GMT
Through the acquisition of the assets of Austrian-based ingredient supplier Österreichische Laberzeugung Hundsbichler GmbH, Chr. Hansen will further expand its enzyme production and presence into the traditional segments of specialty cheeses.
Press Releases • Jun 28, 2018 06:12 GMT
With this expansion and modernization Chr. Hansen will be able to stay ahead of consumers’ increasing demands for natural, yet innovative food and beverage products.
Press Releases • Jun 28, 2018 06:01 GMT
CEO Mauricio Graber: “We are pleased to report that we maintained the sales momentum in Q3"
Press Releases • Jun 14, 2018 11:19 GMT
New starter culture secures mild and creamy soft cheesesChr. Hansen’s latest launch helps cheesemakers to produce soft cheese that maintains the desired taste and texture.
Press Releases • Jun 07, 2018 11:31 GMT
Chr. Hansen and FMC Corporation have announced a five-year extension of their collaboration to develop and commercialize natural solutions for the agricultural industry
Press Releases • May 23, 2018 13:36 GMT
Chr. Hansen’s latest launch secures rich flavor, more flexibility and consistent quality for the cheesemaker
Press Releases • May 15, 2018 09:57 GMT
Clinical trial demonstrates that probiotic strain strengthens the defense against gut damage caused by regular use of household painkiller
Press Releases • May 08, 2018 13:02 GMT
Chr. Hansen Holding A/S has entered into an agreement with Klaus Bjerrum to take up the position of Executive Vice President of Natural Colors Division
Press Releases • Apr 18, 2018 03:57 GMT
Prota Therapeutics, the developer of oral immunotherapies to treat food allergies, has partnered with Chr. Hansen. The partnership will assess the world’s best documented probiotic strain, LGG®, in a Phase III clinical trial to develop a treatment for peanut allergy.
About Chr. Hansen A/S
Chr. Hansen is a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed... Show more
Chr. Hansen is a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. We develop and produce cultures, enzymes, probiotics and natural colors for a rich variety of foods, confectionery, beverages, dietary supplements and even animal feed and plant protection. Our product innovation is based on more than 30,000 microbial strains – we like to refer to them as ‘good bacteria’. Our solutions enable food manufacturers to produce more with less – while also reducing the use of chemicals and other synthetic additives – which make our products highly relevant in today’s world. We have been delivering value to our partners – and, ultimately, end consumers worldwide – for over 140 years. We are proud that more than one billion people consume products containing our natural ingredients every day. Revenue in the 2017/18 financial year was EUR 1,097 million. Chr. Hansen was founded in 1874 and is listed on Nasdaq Copenhagen.
- Chr. Hansen A/S
- Boege Allé 10-12
- DK-2970 Hoersholm